Yahoo! Finance: Mays Cancer Center led studies of innovative breast cancer drug that recently gained FDA approval

February 2, 2023

Virginia Kaklamani, MD, director, Breast Oncology Program, Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, and Dr. Patrick Sung, DPhil, interim executive director of Mays Cancer Center, Biochemistry and Structural Biology, are quoted in this story.   Read More

KSAT 12: Lymphedema Treatment Act will cover what health insurance doesn’t

February 2, 2023

Anton Fries, MD, PhD, chief, Division of Plastic and Reconstructive Surgery, was interviewed for this news segment.   Watch Now

Mays Cancer Center led studies of innovative breast cancer drug that recently gained FDA approval

February 1, 2023

The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for elacestrant, a treatment for postmenopausal women and adult men with ER+/HER2- advanced or metastatic breast cancer. The U.S. Food and Drug Administration on Jan. 27 announced it approved the […]

KSAT 12 Q&A: Gynecologic oncologist discusses cervical cancer risk factors

January 27, 2023

Yasmin Lyons, DO, Obstetrics & Gynecology, Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was interviewed live for this news segment.   Read More

UT Health San Antonio-UTSA team studies compounds aimed at brain cancer

January 24, 2023

Basic science generates new drug for treating glioblastoma, the deadliest cancer Glioblastoma multiforme (GBM) is an aggressive brain cancer associated with the worst overall survival rates among all human cancers. Only 65% of GBM patients live one year past diagnosis and only 12% live five years. The late senators Ted Kennedy and John McCain both […]